IR HOME NEWS & EVENTS OVERVIEW PRESS RELEASES EVENTS & PRESENTATIONS STOCK INFORMATION OVERVIEW HISTORIC STOCK LOOKUP INVESTMENT CALCULATOR ANALYST COVERAGE FINANCIALS & FILINGS OVERVIEW SEC FILINGS CORPORATE GOVERNANCE OVERVIEW LEADERSHIP BOARD OF DIRECTORS COMMITTEE COMPOSITION CONTACT IR IR HOME NEWS & EVENTS OVERVIEW PRESS RELEASES EVENTS & PRESENTATIONS STOCK INFORMATION OVERVIEW HISTORIC STOCK LOOKUP INVESTMENT CALCULATOR ANALYST COVERAGE FINANCIALS & FILINGS OVERVIEW SEC FILINGS CORPORATE GOVERNANCE OVERVIEW LEADERSHIP BOARD OF DIRECTORS COMMITTEE COMPOSITION CONTACT IR Ardelyx Showcased Encouraging Data on Treatment Satisfaction and Efficacy of IBSRELA® (tenapanor) for IBS-C at GHAPP 2023 Read more about Ardelyx Showcased Encouraging Data on Treatment Satisfaction and Efficacy of IBSRELA® (tenapanor) for IBS-C at GHAPP 2023 Ardelyx to Present at the H.C. Wainwright 25th Annual Global Investment Conference Read more about Ardelyx to Present at the H.C. Wainwright 25th Annual Global Investment Conference Ardelyx, Inc. Reports Employment Inducement Grants Read more about Ardelyx, Inc. Reports Employment Inducement Grants Ardelyx Reports Second Quarter 2023 Financial Results and Provides 2023 IBSRELA Net Sales Revenue Guidance Read more about Ardelyx Reports Second Quarter 2023 Financial Results and Provides 2023 IBSRELA Net Sales Revenue Guidance Ardelyx, Inc. Reports Employment Inducement Grants Read more about Ardelyx, Inc. Reports Employment Inducement Grants Ardelyx to Report Second Quarter 2023 Financial Results on August 2, 2023 Read more about Ardelyx to Report Second Quarter 2023 Financial Results on August 2, 2023 Ardelyx to Present at the H.C. Wainwright 2nd Annual Kidney Conference Read more about Ardelyx to Present at the H.C. Wainwright 2nd Annual Kidney Conference Ardelyx Announces Acceptance of New Drug Application for Tenapanor for Hyperphosphatemia in China Read more about Ardelyx Announces Acceptance of New Drug Application for Tenapanor for Hyperphosphatemia in China Ardelyx, Inc. Reports Employment Inducement Grants Read more about Ardelyx, Inc. Reports Employment Inducement Grants Leading Proxy Advisory Firms ISS and Glass Lewis Recommend Ardelyx Stockholders Vote in Favor of Proposed Share Increase Read more about Leading Proxy Advisory Firms ISS and Glass Lewis Recommend Ardelyx Stockholders Vote in Favor of Proposed Share Increase Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Current page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last » Subscribe to FAQs Email Alerts Connect
Ardelyx Showcased Encouraging Data on Treatment Satisfaction and Efficacy of IBSRELA® (tenapanor) for IBS-C at GHAPP 2023 Read more about Ardelyx Showcased Encouraging Data on Treatment Satisfaction and Efficacy of IBSRELA® (tenapanor) for IBS-C at GHAPP 2023
Ardelyx to Present at the H.C. Wainwright 25th Annual Global Investment Conference Read more about Ardelyx to Present at the H.C. Wainwright 25th Annual Global Investment Conference
Ardelyx, Inc. Reports Employment Inducement Grants Read more about Ardelyx, Inc. Reports Employment Inducement Grants
Ardelyx Reports Second Quarter 2023 Financial Results and Provides 2023 IBSRELA Net Sales Revenue Guidance Read more about Ardelyx Reports Second Quarter 2023 Financial Results and Provides 2023 IBSRELA Net Sales Revenue Guidance
Ardelyx, Inc. Reports Employment Inducement Grants Read more about Ardelyx, Inc. Reports Employment Inducement Grants
Ardelyx to Report Second Quarter 2023 Financial Results on August 2, 2023 Read more about Ardelyx to Report Second Quarter 2023 Financial Results on August 2, 2023
Ardelyx to Present at the H.C. Wainwright 2nd Annual Kidney Conference Read more about Ardelyx to Present at the H.C. Wainwright 2nd Annual Kidney Conference
Ardelyx Announces Acceptance of New Drug Application for Tenapanor for Hyperphosphatemia in China Read more about Ardelyx Announces Acceptance of New Drug Application for Tenapanor for Hyperphosphatemia in China
Ardelyx, Inc. Reports Employment Inducement Grants Read more about Ardelyx, Inc. Reports Employment Inducement Grants
Leading Proxy Advisory Firms ISS and Glass Lewis Recommend Ardelyx Stockholders Vote in Favor of Proposed Share Increase Read more about Leading Proxy Advisory Firms ISS and Glass Lewis Recommend Ardelyx Stockholders Vote in Favor of Proposed Share Increase